Showing results (151-160 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|October 12, 1999
Phenytoin-folic acid interaction: a lesson to be learnedH Seligmann, I Potasman, B Weller, et al.Clinical Neuropharmacology|January 8, 2000
Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in ratsC Wikell, G Apelqvist, B Carlsson, et al.Clinical Neuropharmacology|April 15, 1999
Intravenous loading of valproate for epilepsyD K Naritoku, S MueedClinical Neuropharmacology|April 15, 1999
3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatmentN Laufer, B Spivak, V Holdengreber, et al.Clinical Neuropharmacology|April 15, 1999
Tremorlytic activity of budipine in Parkinson's diseaseS Spieker, R Eisebitt, S Breit, et al.Clinical Neuropharmacology|January 1, 1993
Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitorH L White, J A AscherClinical Neuropharmacology|January 1, 1993
Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating ScaleJ Angst, P Scheidegger, M StablClinical Neuropharmacology|January 1, 1993
Reversible monoamine oxidase-A inhibitors in social phobiaM R Liebowitz, F Schneier, A Gitow, et al.Clinical Neuropharmacology|January 1, 1984
Essential myoclonus: response to anticholinergic therapyR C DuvoisinPageof 236